The FDA took two actions to expand the use of the antiviral drug Veklury (remdesivir) to certain non-hospitalized adults and pediatric patients for the treatment of mild-to-moderate COVID-19 disease in places such as skilled nursing facilities, home healthcare settings and outpatient facilities.
Read more: FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19